Peripheral arterial disease: Still on the periphery? [1]

British Medical Journal

Volumn 332, Issue 7551, 2006, Pages 1213-

  Belch, Jill ^a   Stansby, Gerry ^b  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT;

ANGINA PECTORIS; ARTERY DISEASE; BLOOD GLUCOSE MONITORING; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; DIET THERAPY; DISEASE ASSOCIATION; EUROPE; EXERCISE; HEART INFARCTION; HUMAN; ISCHEMIC HEART DISEASE; LETTER; MEDICAL SERVICE; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NICOTINE REPLACEMENT THERAPY; NORTH AMERICA; PATIENT CARE; PRIORITY JOURNAL; QUALITY CONTROL; SMOKING CESSATION PROGRAM; STROKE; TRANSIENT ISCHEMIC ATTACK; UNITED KINGDOM; ARTICLE; FINANCIAL MANAGEMENT; NATIONAL HEALTH SERVICE; PERIPHERAL VASCULAR DISEASE; RISK MANAGEMENT;

CONTRACT SERVICES; GREAT BRITAIN; HUMANS; PERIPHERAL VASCULAR DISEASES; RISK MANAGEMENT; STATE MEDICINE;

EID: 33646899089     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. JBS2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice, http://heart. bmjjournals.com/cgi/rep rint/91/suppl_5/v1?ijkey=Pb Mmm2L5wGIMU&ckeytype=ref&siteid=bmjjournals (accessed 22 February 2006).
2. Belch J, Topol E, Agnelli G, Bertrand M. Critical issues in peripheral arterial disease detection and management. Arch Intern Med 2003;163:84-92.
3. Appraisal Consultation Document. Clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events, www.nice.org.uk/page. aspx?o=105159 (accessed 6 July 2005).
4. Tierney S, Fennessy F, Hayes DB. ABC of arterial and vascular disease. Secondary prevention of peripheral vascular disease. BMJ 2000;320:1262-5.